- Home
- ERAS vs CVGW Comparison
ERAS vs CVGW Comparison
Compare ERAS & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- CVGW
- Stock Information
- Founded
- ERAS 2018
- CVGW 1924
- Country
- ERAS United States
- CVGW United States
- Employees
- ERAS N/A
- CVGW N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- CVGW Specialty Foods
- Sector
- ERAS Health Care
- CVGW Consumer Discretionary
- Exchange
- ERAS Nasdaq
- CVGW Nasdaq
- Market Cap
- ERAS 432.6M
- CVGW 429.3M
- IPO Year
- ERAS 2021
- CVGW N/A
- Fundamental
- Price
- ERAS $1.37
- CVGW $23.99
- Analyst Decision
- ERAS Strong Buy
- CVGW Strong Buy
- Analyst Count
- ERAS 6
- CVGW 1
- Target Price
- ERAS $4.83
- CVGW $35.00
- AVG Volume (30 Days)
- ERAS 1.8M
- CVGW 196.7K
- Earning Date
- ERAS 03-20-2025
- CVGW 03-12-2025
- Dividend Yield
- ERAS N/A
- CVGW 3.33%
- EPS Growth
- ERAS N/A
- CVGW N/A
- EPS
- ERAS N/A
- CVGW 0.54
- Revenue
- ERAS N/A
- CVGW $688,323,000.00
- Revenue This Year
- ERAS N/A
- CVGW $8.03
- Revenue Next Year
- ERAS N/A
- CVGW $8.09
- P/E Ratio
- ERAS N/A
- CVGW $44.50
- Revenue Growth
- ERAS N/A
- CVGW 16.87
- 52 Week Low
- ERAS $1.23
- CVGW $20.30
- 52 Week High
- ERAS $3.45
- CVGW $30.58
- Technical
- Relative Strength Index (RSI)
- ERAS 39.36
- CVGW 53.46
- Support Level
- ERAS $1.40
- CVGW $23.30
- Resistance Level
- ERAS $1.61
- CVGW $24.60
- Average True Range (ATR)
- ERAS 0.11
- CVGW 0.84
- MACD
- ERAS 0.01
- CVGW 0.12
- Stochastic Oscillator
- ERAS 4.00
- CVGW 70.28
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About CVGW Calavo Growers Inc.
Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.